Bonus Biogroup Ltd (BONS)

Bonus Biogroup Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	1.38	1.38	0.25
Debt / EBITDA Ratio	-	-0.38	-0.27
Debt / FCF Ratio	-0.44	-0.44	-0.27
Quick Ratio	0.91	0.91	4.47
Return on Equity (ROE)	-399.97%	-399.97%	-97.35%
Return on Assets (ROA)	-118.88%	-118.88%	-63.55%
Return on Capital (ROIC)	-168.38%	-168.38%	-81.17%
Return on Capital Employed (ROCE)	-	-179.70%	-76.43%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).